James Richard Frost

Title: James Richard Frost: Innovator in Immunomodulation

Introduction

James Richard Frost is a prominent inventor based in Slough, Great Britain. With a keen focus on medical advancements, he has developed innovative solutions aimed at addressing critical health issues. His significant contribution to the field of immunology has been recognized through his patent, which showcases his expertise and dedication to improving human health.

Latest Patents

James Richard Frost holds a notable patent for "Fused Imidazole Derivatives as IL-17 Modulators." This patent encompasses a series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and their analogues, recognized as potent modulators of human IL-17 activity. This advancement is pivotal for the treatment and prevention of various human ailments, specifically targeting inflammatory and autoimmune disorders.

Career Highlights

Frost is associated with UCB Biopharma Srl, a company known for its commitment to developing innovative therapies in the pharmaceutical sector. Through his role, he actively participates in research and development projects that aim to create next-generation treatment options, significantly impacting patient care.

Collaborations

Throughout his career, James has collaborated with esteemed coworkers such as Gareth Neil Brace and Rose Elizabeth Bardell-Cox. These partnerships have fostered a collaborative environment, encouraging the exchange of ideas and facilitating breakthroughs in medicinal chemistry and pharmacology.

Conclusion

James Richard Frost's contributions to the field of immunology through his patent for fused imidazole derivatives exemplify the important work being done by inventors in the healthcare sector. His collaboration with experienced professionals at UCB Biopharma Srl further highlights the collective effort required to advance medical science and improve treatment outcomes for patients suffering from inflammatory and autoimmune disorders.